Share on Facebook Share on Twitter Email
Answers.com

Taisho Pharmaceutical

 
Hoover's Profile: Taisho Pharmaceutical Co., Ltd.
 
(Tokyo:45350)
Contact Information
Taisho Pharmaceutical Co., Ltd.
24-1, Takada 3-chome, Toshima-ku
Tokyo 170-8633, Japan
Tel. +81-3-3985-1111
Fax +81-3-3985-6485

Type: Public
On the web: http://www.taisho.co.jp
Employees: 5,372

Taisho Pharmaceutical would like to keep you healthy -- with or without a prescription. The company makes prescription drugs and various over-the-counter remedies, as well as other healthful products. Its prescription products include Clarith and Tomiron antibiotics and Ancaron for cardiac arrhythmia. Taisho has a joint venture with Toyama Chemical to expand its offerings. The company's other operating segment includes such OTC products as the Pabron line of cold remedies, Colac digestive aids, and RiUp for male pattern baldness. Since Taisho understands that you are what you eat, it makes a variety of nutritional drinks and health foods under such brands as Zena, Lipovitan, and Livita.

Key numbers for fiscal year ending March, 2008:
Sales: $1,855.3M

Officers:
Chairman: Shoji Uehara
President: Akira Uehara
General Manager, Public Relations: Makoto Funahashi

Competitors:
Astellas
Chugai
Takeda Pharmaceutical

Search unanswered questions...
Enter a word or phrase...
All Community Q&A Reference topics
Wikipedia: Taisho Pharmaceutical
 

Taisho Pharmaceutical Co., Ltd. (大正製薬株式会社 Taishō Seiyaku Kabushiki-gaisha?) (TYO: 4535) is a Japanese pharmaceutical company based in Tokyo.

Contents

History

Taisho was established in 1912 to produce over-the-counter drugs. The company moved into prescription drug R&D in 1955.

Products

The company's principal line of business is over-the-counter (OTC) medicines, where it markets the brands Lipovitan-D, Pabron, Colac, and others. In prescription pharmaceuticals, the company's most successful product to date has been the macrolide antibiotic clarithromycin. The company's branded version of the drug, Clarith, was launched in Japan in 1991. For clarithromycin distribution outside Japan Taisho licensed Abbott Laboratories.

Ownership

Taisho Pharmaceutical's stock is traded on the Tokyo Stock Exchange where its security code is 4535. Principal owners of the firm are the Uehara family.

External links


 
 

 

Copyrights:

Hoover's Profile. ©2008 Hoover's, Inc. All rights reserved.  Read more
Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Taisho Pharmaceutical" Read more